SPINT2 and ovarian carcinoma: Among others, SPINT2 was associated with metastatic osteosarcoma [54], ovarian cancer [55], glioma/glioblastoma [56,57], prostate cancer [58] and non-small lung cancer [59], leukemia [60] and cervical carcinoma [61].